ENDONOVO THERAPEUTICS, INC. (ENDV)

0.00 +0.00% (+0.00)

Over 1Y: -50.0%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0 0 0
Jul Sep Nov Jan Mar May Jul

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '18 — Revenue: 42.1K Q4 '18 — Operating Cash Flow: -716.1K Q4 '18 — Free Cash Flow: -716.1K Q4 '18 — Net Income: 1.4M Q1 '19 — Revenue: 45K Q1 '19 — Operating Cash Flow: -528.2K Q1 '19 — Net Income: -2.4M Q2 '19 — Revenue: 62.7K Q2 '19 — Operating Cash Flow: -687.6K Q2 '19 — Net Income: -7.8M Q3 '19 — Revenue: 54K Q3 '19 — Operating Cash Flow: -1M Q3 '19 — Free Cash Flow: -1M Q3 '19 — Net Income: -1.4M Q4 '19 — Revenue: 148.4K Q4 '19 — Operating Cash Flow: -308.4K Q4 '19 — Free Cash Flow: -308.4K Q4 '19 — Net Income: -5.7M Q1 '20 — Revenue: 69.7K Q1 '20 — Operating Cash Flow: -297.2K Q1 '20 — Net Income: 4.3M Q2 '20 — Revenue: 44.6K Q2 '20 — Operating Cash Flow: -154.8K Q2 '20 — Net Income: -1.6M Q3 '20 — Revenue: 40K Q3 '20 — Operating Cash Flow: -96.7K Q3 '20 — Net Income: -1.1M Q4 '20 — Revenue: 11.5K Q4 '20 — Operating Cash Flow: -192.9K Q4 '20 — Net Income: -2M Q1 '21 — Revenue: 34.7K Q1 '21 — Operating Cash Flow: -289.9K Q1 '21 — Net Income: -2.7M Q2 '21 — Revenue: 30.3K Q2 '21 — Operating Cash Flow: -135.9K Q2 '21 — Net Income: -1.3M Q3 '21 — Revenue: 7.8K Q3 '21 — Operating Cash Flow: -169.4K Q3 '21 — Net Income: -1.5M Q4 '21 — Revenue: 316 Q4 '21 — Operating Cash Flow: -391.3K Q4 '21 — Net Income: 2.4M Q1 '22 — Revenue: 2.3K Q1 '22 — Operating Cash Flow: -123K Q1 '22 — Net Income: -2.4M Q2 '22 — Revenue: 650 Q2 '22 — Operating Cash Flow: -206.5K Q2 '22 — Net Income: -2.5M Q3 '22 — Revenue: 11K Q3 '22 — Operating Cash Flow: -123.9K Q3 '22 — Net Income: -603.4K Q4 '22 — Revenue: 121.5K Q4 '22 — Operating Cash Flow: -225.5K Q4 '22 — Net Income: -12.9M Q1 '23 — Revenue: 87.5K Q1 '23 — Operating Cash Flow: -173.2K Q1 '23 — Net Income: 7.2M Q2 '23 — Revenue: 45.2K Q2 '23 — Operating Cash Flow: -165.8K Q2 '23 — Net Income: 2.1M Q3 '23 — Revenue: 1.5K Q3 '23 — Operating Cash Flow: -65.4K Q3 '23 — Net Income: -766.2K -10M -5M 0 5M 10M
Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2023-09-30, reported in USD. The newest fact in the filings is dated 2023-12-31, 973 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.4
SBC / sales 17.6%
OE margin -263.9%
Oper. margin -1023.2%
Accruals -462.7%
Gross margin 96.2%
EBITDA margin -770.2%
FCF margin -246.3%
OCF margin -246.3%
ROA -539.9%
Capex / sales —
OCF / EBIT —
Profit margin —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.0015×
Cash runway —
Cash / Debt 0.0×
F-score 3.0 pts
Quick ratio 0.0015×
Debt / Eq —
Debt payback —
Equity / Assets —
Interest cover —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.9
Sales/sh Y/Y +673.2%
Sales CAGR 4Y +12.9%
Sales Q/Q -86.1%
Shares change +132.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.